Nicotinamide Phosphoribosyltransferase Inhibitor Is a Novel Therapeutic Candidate in Murine Models of Inflammatory Lung Injury Article

Moreno-Vinasco, Liliana, Quijada, Hector, Sammani, Saad et al. (2014). Nicotinamide Phosphoribosyltransferase Inhibitor Is a Novel Therapeutic Candidate in Murine Models of Inflammatory Lung Injury . American Journal of Respiratory Cell and Molecular Biology, 51(2), 223-228. 10.1165/rcmb.2012-0519OC

Open Access

cited authors

  • Moreno-Vinasco, Liliana; Quijada, Hector; Sammani, Saad; Siegler, Jessica; Letsiou, Eleftheria; Deaton, Ryan; Saadat, Laleh; Zaidi, Rafe S; Messana, Joe; Gann, Peter H; Machado, Roberto F; Ma, Wenli; Camp, Sara M; Wang, Ting; Garcia, Joe GN

sustainable development goals

publication date

  • August 1, 2014

published in

keywords

  • APOPTOSIS
  • BIOSYNTHESIS INHIBITOR
  • Biochemistry & Molecular Biology
  • COLONY-ENHANCING FACTOR
  • Cell Biology
  • FK-866
  • FK866
  • GENE
  • Life Sciences & Biomedicine
  • NAD
  • PATHWAY
  • Respiratory System
  • Science & Technology
  • apoptosis
  • nicotinamide phosphoribosyltransferase
  • polymorphonuclear neutrophil
  • vascular endothelium

Digital Object Identifier (DOI)

start page

  • 223

end page

  • 228

volume

  • 51

issue

  • 2